logo
Investors flock to Chinese herbal medicine stock with no revenues

Investors flock to Chinese herbal medicine stock with no revenues

UPI3 days ago

Regencell Bioscience Holdings' NASDAQ stock price rallied with a 280% increase on Monday and another 25% on Tuesday after a recent 38-for-1 stock split took effect on Thursday. File Photo by Angelina Katsanis/UPI | License Photo
June 17 (UPI) -- Shares in Hong Kong-based Regencell Bioscience Holdings nearly quadrupled in value amid a 38-to-1 stock split despite the firm reporting no revenues.
The stock split triggered a 280% share price increase on Monday, CNBC reported, and continued a 58,000% increase in its price in 2025, with a closing cost of $78 per share on the NASDAQ trading platform on Tuesday.
The stock reached a high of $81.23 during morning trading and slumped slightly to $75.47 during Tuesday's after-hours trading.
The stock is rated as a "buy" on the TipRanks website after Regencell officials on June 2 announced the stock split to improve its liquidity and value for shareholders.
The stock split gave investors 37 shares for each share held on June 12. The shares began trading on a split-adjusted basis on Monday, according to Seeking Alpha.
The firm has no reported revenue but says it is developing a Chinese herbal treatment for childhood attention deficit hyperactivity disorder and autism.
The firm was established in 2014 and has been traded on NASDAQ under the RGC symbol since 202.
It had a market capitalization of $29.7 billion at the end of trading on Monday.
The market capitalization rose another 25% on Tuesday, with a total value of $36 billion.
The stock traded for pennies per share last year but now has a greater market value than highly recognized businesses, including Kraft Heinz, Lululemon and eBay, according to CNBC.
Part of the increased investor interest is due to Health and Human Services Secretary Robert Kennedy Jr. raising awareness of alternative medicines.
Regencell Chief Executive Officer Yat-Gai Au controls more than 86% of the company's outstanding shares, according to FactSet.
Little information is available about the potential effectiveness of the company's claims regarding its three traditional Chinese medicine formulas that are supposed to treat mild to severe forms of ADHD and autism with natural herbal medications in liquid form.
Company officials in October reported no generated revenue and no regulatory approvals for its three liquid medicines.
They reported net losses of $6.06 million in 2023 and $4.36 million in 2024.
A Regencell patient case study in late 2023 said 28 patients were treated over three months during a second trial, which showed improvements in ADHD and autism.
A dozen patients participated in a 2021 study to treat COVID-19, which indicated improvement in their symptoms.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Brenmiller Energy Appoints Boaz Toshav to Serve as an Independent Director on the Board
Brenmiller Energy Appoints Boaz Toshav to Serve as an Independent Director on the Board

Miami Herald

time5 minutes ago

  • Miami Herald

Brenmiller Energy Appoints Boaz Toshav to Serve as an Independent Director on the Board

Experienced Global Investment Executive and Strategic Advisor to Support the Company's Next Phase of Growth ROSH HA'AYIN, IL / ACCESS Newswire / June 20, 2025 / Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy", or the "Company") (Nasdaq:BNRG), a leading global provider of Thermal Energy Storage (TES) solutions for industrial and utility customers, today announced the appointment of Mr. Boaz Toshav as an Independent Director to its Board of Directors (the "Board"), effective immediately. Mr. Toshav previously served on the Company's Board from June 2023 until August 2024. Mr. Toshav has over 20 years of experience in investment banking, fixed income and mergers and acquisitions advisory services. He is currently President and Chairman of Rio Ave FC (Primeira Liga), a professional Portuguese football (soccer) club, and he previously served as a senior financial advisor to UK-based Nottingham Forest FC and Greece-based Olympiacos FC. Mr. Toshav also currently serves as the Chief Executive Officer of Umbrella Advisors Ltd., a boutique investment bank and financial advisory firm he founded in 2014. Mr. Toshav has also been a board member of Intelicanna Ltd. (TASE: INTL) and Getruck Ltd. since 2018 and 2021, respectively. Mr. Toshav received a Bachelor of Arts degree in Economics and Business Administration from Tel Aviv University, as well as a Master of Philosophy from Tel Aviv University. Mr. Toshav qualified as a United Kingdom Financial Services Authority certified investment advisor in 2005. "We are honored to welcome Boaz back to our Board," said Avi Brenmiller, Chairman and Chief Executive Officer of Brenmiller Energy. "His proven ability to navigate financial markets, advise boards, and drive strategic partnerships will be instrumental as we enter a pivotal moment in our Company's evolution. With multiple commercial projects underway and a growing global footprint, we believe that Boaz's appointment will strengthen our governance and position us to realize significant value creation for our shareholders." Mr. Toshav succeeds Ms. Nava Swersky Sofer, who concluded her term on the Board following six years of dedicated service. Ms. Swersky Sofer's departure was in accordance with the natural expiration of her term and was not the result of any disagreement with the Company. The Board and management extend their sincere appreciation for her strategic insight and leadership during a period of meaningful growth and transformation at Brenmiller Energy. This appointment follows Brenmiller's recent strategic milestones, including project deployments in Europe, Israel, and the United States. Notably, the European Hydrogen Bank has granted SolWinHy Cádiz S.L. (the "SolWinHy Project") in Arcos de la Frontera, Spain, €25 million in funding. SolWinHy is a special purpose company jointly owned by leading renewable energy developers Green Enesys Group ("Green Enesys") and Viridi RE ("Viridi") to build new green hydrogen and green e-methanol projects in Europe. Green Enesys and Viridi are Brenmiller's joint venture partners in Brenmiller Europe S.L. ("Brenmiller Europe"). The Company estimates its supply of the bGen™ TES system for the SolWinHy Project to be approximately €7 million. The Company believes that its involvement with the SolWinHy Project reinforces the strength of its bGen™ technology and the Company's role in enabling renewable fuel production at scale. Brenmiller continues to expand its role as a key enabler of flexible, clean industrial heat in support of global net-zero targets. About Brenmiller Energy Ltd. Brenmiller Energy helps energy-intensive industries and power producers end their reliance on fossil fuel boilers. Brenmiller's patented bGen™ ZERO thermal battery is a modular and scalable energy storage system that turns renewable electricity into zero-emission heat. It charges using low-cost renewable electricity and discharges a continuous supply of heat on demand and according to its customers' needs. The most experienced thermal battery developer on the market, Brenmiller operates the world's only gigafactory for thermal battery production and is trusted by leading multinational energy companies. For more information visit the Company's website at and follow the company on X and LinkedIn. Forward-Looking Statements: This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company uses forward-looking statements when it discusses: the Company's belief that Mr. Toshav's appointment will strengthen the Company's governance and position to realize significant value creation for shareholders; that the Company s entering a pivotal moment in its evolution; future commercial projects underway and a growing global footprint; the Company's estimates for its supply of the bGen™ TES system for the SolWinHy Project to be approximately €7 million; that the Company's involvement with the SolWinHy Project reinforces the strength of its bGen™ technology; the Company's role as a key enabler of flexible, clean industrial heat in support of global net-zero targets. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this press release. Factors that may affect the Company's results include, but are not limited to: the Company's planned level of revenues and capital expenditures; risks associated with the adequacy of existing cash resources; the demand for and market acceptance of our products; impact of competitive products and prices; product development, commercialization or technological difficulties; the success or failure of negotiations; trade, legal, social and economic risks; and political, economic and military instability in the Middle East, specifically in Israel. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's Annual Report on Form 20-F for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission ("SEC") on March 4, 2025, which is available on the SEC's website, The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. Contact: investors@ SOURCE: Brenmiller Energy

Illegal Mosquito Incense Sticks Spark Concern in Western India: Good Knight Survey
Illegal Mosquito Incense Sticks Spark Concern in Western India: Good Knight Survey

Business Upturn

time8 minutes ago

  • Business Upturn

Illegal Mosquito Incense Sticks Spark Concern in Western India: Good Knight Survey

67% of West Indian residents feel uneasy using unregulated mosquito products, highlights growing health risk. By Riddhima Jain Published on June 20, 2025, 16:57 IST Last updated June 20, 2025, 17:00 IST A recent survey by Good Knight, a leading household insecticide brand from Godrej Consumer Products Ltd. (GCPL), has revealed growing unease among residents of Western India regarding the use of illegal mosquito repellent incense sticks. The study, titled 'One Mosquito, Countless Threats,' was conducted by market research firm YouGov and shows that 67% of people in the region feel uncomfortable or irritated when using such unregulated products. The report further highlights that 60% of respondents in the western region—which includes Maharashtra, Gujarat, Goa, and Madhya Pradesh—are highly selective about the mosquito repellents they use, emphasizing a strong preference for government-approved, safe products. In fact, 75% of West Indian consumers opt for officially approved repellents, despite the growing presence of illegal alternatives. Nationally, 69% of respondents shared similar discomfort, with East India leading the concern at 73%. The report also shows that both men (70%) and women (67%) are nearly equally disturbed by these products, which often contain unregistered Chinese chemicals. The illegal mosquito incense stick market is rapidly growing, currently valued at ₹320 crore in Western India alone, out of a national market size of ₹1600 crore, and is expanding by 20% annually. Maharashtra is reportedly the largest market for these illegal products in the region, followed by Madhya Pradesh and Gujarat. Speaking on the findings, Shilpa Suresh, Head of Marketing – Home Care at GCPL, said, 'Many of these incense sticks are illegally manufactured and pose serious health risks. Good Knight remains committed to offering science-backed, safe, and government-approved mosquito solutions for Indian homes.' Echoing these concerns, Jayant Deshpande, Honorary Secretary of the Home Insects Control Association (HICA), called the use of illegal mosquito incense sticks 'a silent killer entering homes.' He urged citizens to check for CIBRC registration numbers on repellent packaging to ensure safety and authenticity. Ahmedabad Plane Crash

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store